The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARIX.L Regulatory News (ARIX)

  • There is currently no data for ARIX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Unaudited NAV for November 2023

13 Dec 2023 07:00

Arix Bioscience PLC (ARIX) Unaudited NAV for November 2023 13-Dec-2023 / 07:00 GMT/BST


 

Arix Bioscience plc

 

Unaudited NAV for November 2023

 

LONDON, 13 December 2023: Arix Bioscience plc (“Arix” or the “Company”) (LSE: ARIX), a transatlantic venture capital company focused on investing in breakthrough biotechnology companies, announces the unaudited estimated Net Asset Value (“NAV”) of the Company for the date ended 30 November 2023 as follows:

 

Date

NAV Breakdown

Total NAV

 

NAV per share

Listed Portfolio

Unlisted Portfolio

Cash

Other Interests

30 November 2023

(unaudited)

£54.3m

£66.4m

£105.8m

£2.6m

£229.1m

£1.77

 

 

[ENDS]

 

Enquiries

For more information on Arix, please contact:

 

Arix Bioscience plc

+44 (0)20 7290 1050

ir@arixbioscience.com

 

Powerscourt

Sarah MacLeod, Nick Johnson, Molly Ring

+44 (0)20 7250 1446

arix@powerscourt-group.com

 

About Arix Bioscience plc

Arix Bioscience plc is a transatlantic venture capital company focused on investing in breakthrough biotechnology companies around cutting-edge advances in life sciences.

 

We collaborate with exceptional entrepreneurs and provide the capital, expertise, and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors. www.arixbioscience.com

 

 


Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
ISIN:GB00BD045071
Category Code:MSCM
TIDM:ARIX
LEI Code:213800OVT3AHQCXNIX43
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:291541
EQS News ID:1795525
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
1st Oct 20217:00 amEQSTotal Voting Rights
30th Sep 20215:30 pmEQSTransaction in own shares
29th Sep 20215:30 pmEQSTransaction in own shares
28th Sep 20215:30 pmEQSTransaction in own shares
28th Sep 20218:16 amEQSArtios Doses First Patient in Phase 1/2a Study of Polθ Inhibitor ART4215
27th Sep 20215:30 pmEQSTransaction in own shares
24th Sep 20215:30 pmEQSTransaction in own shares
23rd Sep 20215:30 pmEQSTransaction in own shares
22nd Sep 20215:30 pmEQSTransaction in own shares
21st Sep 20216:00 pmEQSTransaction in own shares
20th Sep 20215:30 pmEQSTransaction in own shares
17th Sep 20215:30 pmEQSTransaction in own shares
16th Sep 20216:00 pmEQSTransaction in own shares
15th Sep 20215:30 pmEQSTransaction in own shares
14th Sep 20215:30 pmRNSTransaction in own shares
13th Sep 20215:30 pmEQSTransaction in own shares
10th Sep 20215:30 pmEQSTransaction in own shares
9th Sep 20215:30 pmEQSTransaction in own shares
8th Sep 20215:30 pmEQSTransaction in own shares
7th Sep 20215:30 pmEQSTransaction in own shares
3rd Sep 20215:30 pmEQSTransaction in own shares
2nd Sep 20215:30 pmEQSTransaction in own shares
2nd Sep 202111:21 amEQSArix Bioscience participates in $90 million Series B financing for Disc Medicine
1st Sep 20215:30 pmEQSTransaction in own shares
1st Sep 20217:00 amEQSTotal Voting Rights
31st Aug 20215:30 pmEQSTransaction in own shares
27th Aug 20215:30 pmEQSTransaction in own shares
26th Aug 20215:30 pmEQSTransaction in own shares
25th Aug 20215:30 pmEQSTransaction in own shares
24th Aug 20215:30 pmEQSTransaction in own shares
23rd Aug 20215:30 pmEQSTransaction in own shares
20th Aug 20215:30 pmEQSTransaction in own shares
19th Aug 20215:15 pmEQSTransaction in own shares
18th Aug 20215:30 pmEQSTransaction in own shares
17th Aug 20215:45 pmEQSTransaction in own shares
16th Aug 20215:30 pmEQSTransaction in own shares
16th Aug 20217:00 amEQSDirector/PDMR Shareholding
13th Aug 20215:30 pmEQSTransaction in own shares
12th Aug 20215:30 pmEQSTransaction in own shares
12th Aug 20217:01 amEQSInterim Results for the Six Months Ended 30 June 2021
11th Aug 20215:30 pmEQSTransaction in own shares
10th Aug 20215:30 pmEQSTransaction in own shares
9th Aug 20215:30 pmEQSTransaction in own shares
6th Aug 20215:30 pmEQSTransaction in own shares
5th Aug 20215:15 pmEQSTransaction in own shares
4th Aug 20215:28 pmEQSTransaction in own shares
3rd Aug 20215:20 pmEQSTransaction in own shares
2nd Aug 20215:25 pmEQSTransaction in own shares
2nd Aug 20217:00 amEQSTotal Voting Rights
30th Jul 20215:15 pmEQSTransaction in own shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.